Zomedica Corp [AMEX: ZOM] stock went on an upward path that rose over 6.30% on Friday, amounting to a one-week price increase of more than 21.30%.
Over the last 12 months, ZOM stock dropped by -21.78%. The one-year Zomedica Corp stock forecast points to a potential upside of 40.0. The average equity rating for ZOM stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $153.01 million, with 979.95 million shares outstanding and 962.66 million shares in the current float. Compared to the average trading volume of 5.84M shares, ZOM stock reached a trading volume of 27990835 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Zomedica Corp [ZOM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ZOM shares is $0.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ZOM stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Dawson James have made an estimate for Zomedica Corp shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 06, 2023.
The Average True Range (ATR) for Zomedica Corp is set at 0.01, with the Price to Sales ratio for ZOM stock in the period of the last 12 months amounting to 5.72. The Price to Book ratio for the last quarter was 0.71, with the Price to Cash per share for the same quarter was set at 0.07.
ZOM Stock Performance Analysis:
Zomedica Corp [ZOM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 21.30. With this latest performance, ZOM shares gained by 12.14% in over the last four-week period, additionally plugging by 1.31% over the last 6 months – not to mention a drop of -21.78% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ZOM stock in for the last two-week period is set at 73.22, with the RSI for the last a single of trading hit 81.16, and the three-weeks RSI is set at 67.27 for Zomedica Corp [ZOM]. The present Moving Average for the last 50 days of trading for this stock 0.1258, while it was recorded at 0.1294 for the last single week of trading, and 0.1387 for the last 200 days.
Insight into Zomedica Corp Fundamentals:
Zomedica Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 10.15 and a Current Ratio set at 10.82.
Zomedica Corp [ZOM] Institutonal Ownership Details
There are presently around $8.33%, or 8.48%% of ZOM stock, in the hands of institutional investors. The top three institutional holders of ZOM stocks are: VANGUARD GROUP INC with ownership of 29.93 million shares, which is approximately 3.054%. BLACKROCK INC., holding 26.21 million shares of the stock with an approximate value of $$334.65 million in ZOM stocks shares; and BLACKROCK INC., currently with $$330.43 million in ZOM stock with ownership which is approximately 2.6405%.
